Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

A call to standardize teratoma assays used to define human pluripotent cell lines.

Müller FJ, Goldmann J, Löser P, Loring JF.

Cell Stem Cell. 2010 May 7;6(5):412-4. doi: 10.1016/j.stem.2010.04.009.

2.

Reconsidering pluripotency tests: do we still need teratoma assays?

Buta C, David R, Dressel R, Emgård M, Fuchs C, Gross U, Healy L, Hescheler J, Kolar R, Martin U, Mikkers H, Müller FJ, Schneider RK, Seiler AE, Spielmann H, Weitzer G.

Stem Cell Res. 2013 Jul;11(1):552-62. doi: 10.1016/j.scr.2013.03.001. Review.

3.

Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.

Bulic-Jakus F, Katusic Bojanac A, Juric-Lekic G, Vlahovic M, Sincic N.

Wiley Interdiscip Rev Dev Biol. 2016 Mar-Apr;5(2):186-209. doi: 10.1002/wdev.219. Review.

PMID:
26698368
4.

A survey of parameters involved in the establishment of new lines of human embryonic stem cells.

Fraga AM, Souza de Araújo ÉS, Stabellini R, Vergani N, Pereira LV.

Stem Cell Rev. 2011 Nov;7(4):775-81. doi: 10.1007/s12015-011-9250-x. Review.

PMID:
21416256
5.

Experimental teratoma: at the crossroad of fetal- and onco-development.

Hultman I, Björk L, Blomberg E, Sandstedt B, Ahrlund-Richter L.

Semin Cancer Biol. 2014 Dec;29:75-9. doi: 10.1016/j.semcancer.2014.08.005. Review.

PMID:
25153353
6.

Pluripotency: toward a gold standard for human ES and iPS cells.

Smith KP, Luong MX, Stein GS.

J Cell Physiol. 2009 Jul;220(1):21-9. doi: 10.1002/jcp.21681. Review.

PMID:
19326392
7.

Testicular teratomas: an intersection of pluripotency, differentiation and cancer biology.

Bustamante-Marín X, Garness JA, Capel B.

Int J Dev Biol. 2013;57(2-4):201-10. doi: 10.1387/ijdb.130136bc. Review.

8.

[An overview of pluripotent stem cell lines].

Kieffer E, Kuntz S, Viville S.

Med Sci (Paris). 2010 Oct;26(10):848-54. doi: 10.1051/medsci/20102610848. Review. French.

9.

Pluripotent cells in embryogenesis and in teratoma formation.

Gordeeva OF.

J Stem Cells. 2011;6(1):51-63. Review.

PMID:
22997845
10.

The development of pluripotent stem cells.

Gokhale PJ, Andrews PW.

Curr Opin Genet Dev. 2012 Oct;22(5):403-8. doi: 10.1016/j.gde.2012.07.006. Review.

PMID:
22868175
11.

Teratomas from pluripotent stem cells: A clinical hurdle.

Fong CY, Gauthaman K, Bongso A.

J Cell Biochem. 2010 Nov 1;111(4):769-81. doi: 10.1002/jcb.22775. Review.

PMID:
20665544
12.

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Knoepfler PS.

Stem Cells. 2009 May;27(5):1050-6. doi: 10.1002/stem.37. Review.

13.

Intercellular protein expression variability as a feature of stem cell pluripotency.

Rosner M, Hengstschläger M.

Amino Acids. 2013 Dec;45(6):1315-7. Review.

PMID:
24077670

Supplemental Content

Support Center